Maria Brotons holds a Medical degree (University of Barcelona-UB, 2005), a Master’s degree in Public Health (University Pompeu Fabra-UPF, 2007), and a Medical Specialty in Preventive Medicine and Public Health (Vall d’Hebron University Hospital, 2010)
In 2010 she joined the Cancer Epidemiology Research Program (PREC) in the Catalan Institute of Oncology (ICO) as epidemiologist, and her research topics focus on the epidemiology and prevention of human papillomavirus (HPV) infections and related diseases.
When she joined the PREC, she was involved in the HPV Information Center, a web-based resource lead by ICO and the International Agency for Research on Cancer (IARC) that aims to compile and centralize worldwide updated data and statistics on HPV and related diseases to accelerate the introduction of HPV preventive strategies. As part of the HPV-Information Centre, she participated in several international projects and in a consultancy requested by the European Centre for Disease Prevention and Control (ECDC) to update the HPV vaccination guidelines in the European Union.
Currently, she is a member of the UNIC-I team and her work focuses on the evaluation of the impact of cervical cancer preventative strategies, mainly HPV vaccination. She leads the studies to evaluate the impact of the HPV vaccine introduction in Catalonia, in collaboration with the Catalan Health Department, and these studies are the basis of her thesis project on the impact of HPV vaccination in Catalonia.
She is currently collaborating with the Pan American Health Organization (PAHO) to develop a guideline to assess the impact of HPV vaccination in Latin America. The objectives of this guideline are to provide conceptual and methodological guidance to Latin American and Caribbean countries on measuring the impact of HPV vaccination.